GADOTERATE MEGLUMINE

Search structure
Trade Names:
Synonyms:
Status: Approved (2013)
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: L0ND3981AG

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H42GdN5O13
Molecular Weight 753.86
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
None Diagnostic agent

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Brain Neoplasms 3 D001932 ClinicalTrials
Central Nervous System Diseases 3 D002493 ClinicalTrials
Lung Diseases, Interstitial 2 D017563 ClinicalTrials

Related Entries

MCS

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Skin and subcutaneous tissue disorders
17.53
Respiratory, thoracic and mediastinal disorders
13.27
Immune system disorders
10.34
Gastrointestinal disorders
9.78
General disorders and administration site conditions
9.78
Nervous system disorders
8.8
Cardiac disorders
7.62
Vascular disorders
5.53
Musculoskeletal and connective tissue disorders
3.33
Injury, poisoning and procedural complications
2.83
Psychiatric disorders
2.54
Eye disorders
2.41

Cross References

Resources Reference
ChEBI 73727
ChEMBL CHEMBL2219415
FDA SRS L0ND3981AG
PubChem 6918037
CONTENTS